Literature DB >> 19041152

Temporal trends in the relative cost of dying: evidence from Canada.

Greg Payne1, Audrey Laporte, David K Foot, Peter C Coyte.   

Abstract

OBJECTIVE: To measure change over time in the relationship between health care expenditures for individuals that die in a given year and age matched survivors.
METHODS: Administrative data covered government-funded hospital, physician, prescription drug, and continuing care services for the entire population aged 65 and over in the province of British Columbia between 1991 and 2001. Individuals were separated according to age group and decedent/survivor status. The average utilization cost was estimated for each age group and survivor status in each year from 1991 to 2001. Time trends in decedent and survivor costs, and the ratio between the two, were analyzed for each service category.
RESULTS: Inflation-adjusted decedent costs rose by almost 10% between 1991 and 2001, while survivor costs fell slightly. The ratio of decedent to survivor costs increased for all age groups, and was greatest for hospital and continuing care costs. Although the study population mortality rate fell over the study period, the proportion of health care costs allocated to decedents grew by 8%.
CONCLUSIONS: If mortality rates continue to fall, lower survivor costs and higher decedent costs will lower future growth in health expenditures due to aging.

Entities:  

Mesh:

Year:  2008        PMID: 19041152     DOI: 10.1016/j.healthpol.2008.09.017

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  5 in total

1.  Income inequities in end-of-life health care spending in British Columbia, Canada: A cross-sectional analysis, 2004-2006.

Authors:  Colleen M Cunningham; Gillian E Hanley; Steven G Morgan
Journal:  Int J Equity Health       Date:  2011-03-16

2.  Funding health and social services for older people - a qualitative study of care recipients in the last year of life.

Authors:  Barbara Hanratty; Elizabeth Lowson; Louise Holmes; Gunn Grande; Julia Addington-Hall; Sheila Payne; Jane Seymour
Journal:  J R Soc Med       Date:  2012-04-25       Impact factor: 5.344

Review 3.  Report of the Lancet Commission on the Value of Death: bringing death back into life.

Authors:  Libby Sallnow; Richard Smith; Sam H Ahmedzai; Afsan Bhadelia; Charlotte Chamberlain; Yali Cong; Brett Doble; Luckson Dullie; Robin Durie; Eric A Finkelstein; Sam Guglani; Melanie Hodson; Bettina S Husebø; Allan Kellehear; Celia Kitzinger; Felicia Marie Knaul; Scott A Murray; Julia Neuberger; Seamus O'Mahony; M R Rajagopal; Sarah Russell; Eriko Sase; Katherine E Sleeman; Sheldon Solomon; Ros Taylor; Mpho Tutu van Furth; Katrina Wyatt
Journal:  Lancet       Date:  2022-02-01       Impact factor: 79.321

4.  Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's disease.

Authors:  Spencer A W Lee; Luciano A Sposato; Vladimir Hachinski; Lauren E Cipriano
Journal:  Alzheimers Res Ther       Date:  2017-03-16       Impact factor: 6.982

5.  Proximity to death and health care expenditure increase revisited: A 15-year panel analysis of elderly persons.

Authors:  Viktor von Wyl
Journal:  Health Econ Rev       Date:  2019-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.